Roche: Supportive clinical data of already-approved cancer drugs and PD-L1 product

NEUTRAL, Fair Value CHF252 (+3%)

News published on September Monday 30, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities